Blocking lncRNA HCG18 re-sensitizes Taxol resistant lung cancer cells to Taxol through modulating the miR-34a-5p/HDAC1 axis

Fujun Zhang(Beijing Jiaotong University), Rong Gong(Kunming Medical University), Xiaoyu Luo(Northwest A&F University), Juan Wang(Tianjin Medical University General Hospital), Haoyu Li(Qingdao University), Kai Yang(Kunming Medical University), Lin Liu(Dankook University), Qiuyue Xu(Kunming Medical University), Zijie Liu(Kunming Medical University), Yunmin Xu(Zhejiang A & F University)
Journal of Chemotherapy
May 6, 2024
10.1080/1120009x.2024.2308979
Cited by 2

Related Papers

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
|BMJ|2022|494
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway
|Genome Medicine|2020|192
Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice
|Microbiome|2021|167
Controlling Morphology and Voltage Loss with Ternary Strategy Triggers Efficient All-Small-Molecule Organic Solar Cells
|ACS Energy Letters|2023|120